当前位置: 首页 >> 检索结果
共有 4791 条符合本次的查询结果, 用时 2.9950433 秒

1801. HIV and alcohol misuse among miners in Zimbabwe.

作者: Moira Majaha.;Chido Dziva Chikwari.;Samuel Kizito.;Dingani Moyo.;Fred Ssewamala.
来源: Lancet. 2025年404卷10471期2538页

1802. Combined liver-kidney transplantation: 40 years of saving lives.

作者: Xuyong Sun.;Xiaocong Kuang.;Ning Wen.;Zhiying Lei.;Liugen Lan.;Jihua Wu.;Ke Mo.;Xing Niu.
来源: Lancet. 2025年404卷10471期2538-2539页

1803. From bad to worse: the unbreathable air of Lahore.

作者: Sikandar Khan.
来源: Lancet. 2025年404卷10471期2537-2538页

1804. End non-consensual surgeries on intersex children in Serbia.

作者: Valentina Opancina.;Y Tony Yang.
来源: Lancet. 2025年404卷10471期2536-2537页

1805. Another claw hand in a Renaissance portrait.

作者: Alexis Demas.
来源: Lancet. 2025年404卷10471期2535页

1806. Top ten menopause research priorities.

作者: Zachary Nash.;Monica Christmas.;Toto Gronlund.;Martha Hickey.; .
来源: Lancet. 2025年404卷10471期2535-2536页

1807. European health security needs a reboot in 2025.

作者: The Lancet.
来源: Lancet. 2025年404卷10471期2487页

1808. The perils of RFK Junior's anti-vaccine leadership for public health.

作者: Y Tony Yang.
来源: Lancet. 2025年405卷10473期122页

1809. The first 100 days of the mpox response in Africa.

作者: Nicaise Ndembi.;Yap Boum.;Moréniké O Foláyan.
来源: Lancet. 2025年405卷10473期121-122页

1810. Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.

作者: David T Rubin.;Jessica R Allegretti.;Julián Panés.;Nicole Shipitofsky.;Shadi S Yarandi.;Kuan-Hsiang Gary Huang.;Matthew Germinaro.;Rebbecca Wilson.;Hongyan Zhang.;Jewel Johanns.;Brian G Feagan.;Tadakazu Hisamatsu.;Gary R Lichtenstein.;Brian Bressler.;Laurent Peyrin-Biroulet.;Bruce E Sands.;Axel Dignass.; .
来源: Lancet. 2025年405卷10472期33-49页
Interleukin-23 inhibition is effective in treating ulcerative colitis. Guselkumab is a dual-acting, human IgG1, interleukin-23p19 subunit inhibitor that potently neutralises interleukin-23 and can bind to CD64. We aimed to evaluate the efficacy and safety of guselkumab as induction and maintenance therapy in patients with ulcerative colitis.

1811. Guselkumab in the IL-23 inhibition landscape for ulcerative colitis.

作者: Beatriz Gros.;Laura E Targownik.
来源: Lancet. 2025年405卷10472期2-3页

1812. Assisted dying, complex systems, and global equity in palliative care.

作者: Libby Sallnow.;Beatriz E Dorsey-Rivera.;Christian Ntizimira.;Nezamuddin Ahmad.;Suresh Kumar.
来源: Lancet. 2025年405卷10473期103-105页

1813. Making CAR T-cell therapies more affordable.

作者: Kathryn Senior.
来源: Lancet. 2025年405卷10474期187-188页

1814. What price is society willing to pay for new drugs?

作者: Victoria Charlton.
来源: Lancet. 2025年405卷10472期3-5页

1815. Population-health impact of new drugs recommended by the National Institute for Health and Care Excellence in England during 2000-20: a retrospective analysis.

作者: Huseyin Naci.;Peter Murphy.;Beth Woods.;James Lomas.;Jinru Wei.;Irene Papanicolas.
来源: Lancet. 2025年405卷10472期50-60页
Health systems experience difficult trade-offs when paying for new drugs. In England, funding recommendations by the National Institute for Health and Care Excellence (NICE) for new drugs might generate health gains, but inevitably result in forgone health as the funds cannot be used for alternative treatments and services. We aimed to evaluate the population-health impact of NICE recommendations for new drugs during 2000-20.

1816. Smog once again plagues India and Pakistan.

作者: Talha Burki.
来源: Lancet. 2024年404卷10470期e8页

1817. What will new assisted dying legislation mean for doctors?

作者: Jacqui Thornton.
来源: Lancet. 2024年404卷10470期2408-2409页

1818. New EU Health Commissioner appointed amid controversy.

作者: Marianne Guenot.
来源: Lancet. 2024年404卷10470期2406-2407页

1819. Sarcoidosis of the pituitary gland and stalk in a man presenting asthenia, impotence, loss of libido, polyuria, and polydipsia.

作者: Jérémy Clément.;Adeline Dubois de Mont-Marin.
来源: Lancet. 2024年404卷10470期2460-2461页

1820. Extended optical treatment for children with amblyopia in Europe: the EuPatch trial - Authors' reply.

作者: Frank A Proudlock.;Michael Hisaund.;Eleni Papageorgiou.;Ali Manouchehrinia.;Irene Gottlob.
来源: Lancet. 2024年404卷10470期2421-2422页
共有 4791 条符合本次的查询结果, 用时 2.9950433 秒